arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

Journey Medical Corp

DERM

$6.41 ▼ -0.12 (-1.84%) at close

7 Visible periods

31 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

Journey Medical Corp faces fundamental challenges with weakness in Return on Common Equity (%) and Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $157.0M

Dividend Yield —

Revenue Growth 10.2% ↗

Op. Margin -13.2% ↗

ROIC -14.4% ↗

FCF / Share $-0.51 ↘

Trailing P/E —

Price / Book 4.9x

FCF Yield —

Debt / Equity 0.79

info Valuation on last close. End-of-day price, Aug 7, 2026.

7-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$61.86M

↑ +10.2% —

Net Income Profit after all expenses

$-11.43M

↑ +22.1% —

Operating Margin Operating profit as % of sales

-13.2%

↑ +45.8% 13th

FCF / Share Free cash flow per share

$-0.51

↓ -13.7% —

Long-Term Debt Long-term obligations

$25.28M

↑ +1.6% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Operating Margin (%)Operating Margin (%) is in the bottom quartile
Profit Margin (%)Profit Margin (%) is in the bottom quartile
Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability ↑

Returns ↑

Financial Health →

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
Revenue Growth YoY (%)	10.2% Good ↑ Good Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+27%)	-29.1% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-464%)	7.5% Fair ↓ Fair Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-6%)	16.7% Good Good Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+109%)	41.8% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+422%)	—	—
EPS Growth YoY (%)	34.7% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-242.9% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	87.6% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	60.9% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	N/M	—	—
Net Income Growth YoY (%)	22.1% Good ↑ Good Improving Year-over-year change in net income	-280.8% Weak ↓ Weak Declining Year-over-year change in net income	87.0% Excellent Excellent Year-over-year change in net income	32.7% Excellent Excellent Year-over-year change in net income	N/M	—	—
FCF Growth YoY (%)	-13.7% Weak Weak Year-over-year change in free cash flow	N/M	N/M	-260.7% Weak Weak Year-over-year change in free cash flow	N/M	—	—
Revenue CAGR 3Y (%)	-5.7% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-3.8% Weak Weak Compound annual revenue growth over 3 years	21.1% Excellent Excellent Compound annual revenue growth over 3 years	—	—	—	—
Revenue CAGR 5Y (%)	6.8% Fair Fair Compound annual revenue growth over 5 years	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
Operating Margin (%) (%)	-13.2% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-188%)	-24.4% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-262%)	-2.6% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-117%)	-37.4% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-349%)	-55.2% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-468%)	17.6% Fair Fair Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+18%)	—
Effective Tax Rate (%) (%)	-0.5% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.4% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-6.1% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.2% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-3.9% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	26.1% Caution Caution Actual taxes paid relative to pre-tax income Optimal: 15-25%	—
Profit Margin (%) (%)	-18.5% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-254%)	-26.1% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-318%)	-4.9% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-141%)	-40.2% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-435%)	-69.7% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-681%)	11.9% Fair Fair Net income as a percentage of revenue Optimal: > 15% vs Sector: At sector avg	—
FCF Margin (%) (%)	-20.1% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-16.3% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	6.6% Caution ↑ Caution Improving Free cash flow as a percentage of revenue Optimal: > 10%	-18.4% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-3.5% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	11.5% Fair Fair Free cash flow as a percentage of revenue Optimal: > 10%	—
FCF / Net Income (x)	1.09x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.62x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	-1.36x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.46x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.05x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.97x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
Return on Invested Capital (%)	-14.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-30.6% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-6.3% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-61.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-86.2% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	56.3% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-8.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-17.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-2.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-26.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-35.9% Weak Weak Operating profit relative to total assets Optimal: > 10%	15.1% Excellent Excellent Operating profit relative to total assets Optimal: > 10%	—
Return on Common Equity (%) (%)	-35.9% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-339%)	-73.1% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-587%)	-18.9% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-226%)	-174.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1263%)	-104.6% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-798%)	51.3% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+242%)	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
Debt to Equity (x)	0.79x Fair ↓ Fair Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+32%)	1.24x Caution ↑ Caution Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+107%)	0.72x Fair Fair Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+20%)	1.63x Weak Weak Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+172%)	—	—	—
Interest Coverage (x)	-2.21x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-5.07x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-1.22x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-13.63x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-4.96x Weak Weak Operating income divided by interest expense Optimal: > 5x	11.25x Excellent Excellent Operating income divided by interest expense Optimal: > 5x	—
Net Debt (USD)	$1.19M	$4.57M	$-12.82M	$-4.24M	$-49.08M	$-8.25M	—
Debt / EBITDA (x)	-3.09x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-1.82x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-7.05x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-1.01x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
Revenue per Share (USD)	$2.53	$2.75	$4.34	$4.20	$6.20	$4.87	—
Basic EPS, GAAP (USD)	$-0.47	$-0.72	$-0.21	$-1.69	$-4.32	$0.58	—
Free Cash Flow per Share (USD)	$-0.51	$-0.45	$0.29	$-0.77	$-0.21	$0.56	—
Book Value per Share (USD)	$1.30	$0.98	$1.12	$0.97	$4.13	$1.13	—
Tangible Book Value per Share (USD)	$0.17	$-0.58	$0.00	$-0.58	$2.89	$-0.52	—
Basic Weighted Avg Shares (shares)	24.50M	20.43M	18.23M	17.53M	10.19M	9.14M	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
Working Capital (USD)	$29.43M	$13.00M	$14.59M	$10.85M	$32.88M	$7.18M	—
LT Debt (USD)	$25.28M	$24.88M	$14.62M	$27.77M	—	—	—
Total Equity (USD)	$31.85M	$20.07M	$20.35M	$16.98M	$42.04M	$10.29M	$2.75M

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
Sales/Revenue/Turnover (USD)	$61.86M	$56.13M	$79.18M	$73.67M	$63.13M	$44.53M	—
Depreciation Expense (USD)	—	—	—	—	—	$5.00K	—
Net Income, GAAP (USD)	$-11.43M	$-14.67M	$-3.85M	$-29.63M	$-43.99M	$5.28M	—
Operating Cash Flow (USD)	$-12.44M	$-9.13M	$5.24M	$-13.53M	$-2.18M	$5.13M	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 7 years · 25 quarters

Journey Medical Corp

Analytical Summary

7-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare DERM with peers